DISSOLUTION TIME, ON RECONSTITUTION, OF A NEW PARENTERAL FORMULATION OF DOXORUBICIN (DOXORUBICIN RAPID DISSOLUTION)

被引：4
|
作者：
MURPHY, A
MALTBY, S
LAUNCHBURY, AP
机构：
[1] FARMITALIA CARLO ERBA LTD,ST ALBANS AL1 3AW,ENGLAND
[2] BELVOIR PK HOSP,BELFAST,NORTH IRELAND
[3] ROYAL MARSDEN HOSP,LONDON,ENGLAND
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1987年 / 38卷 / 1-3期
关键词：
D O I：
10.1016/0378-5173(87)90124-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：257 / 259
页数：3
相关论文
共 50 条
  • [21] VALIDATION OF THE INVITRO DISSOLUTION METHOD USED FOR A NEW SUSTAINED-RELEASE THEOPHYLLINE PELLET FORMULATION
    DIETRICH, R
    BRAUSSE, R
    BAUTZ, A
    DILETTI, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (8A): : 1220 - 1228
  • [22] Physical properties and dissolution of a new formulation for pediatric, geriatric and taste-masking applications.
    Stoller, BM
    Coffey, MJ
    Lu, GW
    Ewing, GD
    Ciolkowski, EL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U492 - U492
  • [23] A NEW TECHNIQUE FOR THE RAPID DISSOLUTION OF RETAINED DUCTAL GALLSTONES WITH MONOCTANOIN IN T-TUBE PATIENTS
    JANSSEN, D
    BOMMARITO, A
    LATHROP, J
    AMERICAN SURGEON, 1992, 58 (02) : 141 - 145
  • [24] Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation
    Horkovics-Kovats, Stefan
    Brunovsky, Pavel
    Pichler, Arthur
    Bulitta, Juergen B.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 78 : 245 - 254
  • [25] Development of a New RP-UPLC Method for the Determination of Rabeprazole Sodium in Pharmaceutical Formulation and Application in Dissolution Studies
    Karunakaran, K.
    Navaneethan, G.
    Elango, K. P.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (05) : 655 - 661
  • [26] Simulating different dosing scenarios for a paediatric valproic acid ER formulation in a new paediatric multistage dissolution model
    Karkossa, Frank
    Urbaniak, Jana
    Klein, Sandra
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 536 (02) : 520 - 520
  • [27] ENHANCEMENT OF DISSOLUTION RATE AND FORMULATION DEVELOPMENT OF RITONAVIR TABLETS EMPLOYING STARCH PHOSPHATE-A NEW MODIFIED STARCH
    Chowdary, K. P. R.
    Enturi, Veeraiah
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (07): : 1730 - 1735
  • [28] A new theranostic pH-responsive niosome formulation for doxorubicin delivery and bio-imaging against breast cancer
    Saharkhiz, Shaghayegh
    Zarepour, Atefeh
    Zarrabi, Ali
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 637
  • [29] Initial phase I trial of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors.
    Izquierdo, MA
    Balañá, C
    Fabregat, X
    García, M
    Martinez, M
    Llorens, MA
    Gimeno, M
    Mesia, R
    Rosell, R
    Germá, JR
    CLINICAL CANCER RESEARCH, 1999, 5 : 3795S - 3795S
  • [30] In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model
    Wong, Ho Lun
    Rauth, Andrew Mike
    Bendayan, Reina
    Wu, Xiao Yu
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (03) : 300 - 308
12345